Ignite Creation Date:
2025-12-25 @ 3:49 AM
Ignite Modification Date:
2026-02-09 @ 12:11 AM
Study NCT ID:
NCT04511702
Status:
COMPLETED
Last Update Posted:
2025-10-17
First Post:
2020-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-11
First Submit QC Date:
None
Study First Post Date:
2020-08-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-12-12
Results First Submit QC Date:
None
Results First Post Date:
2025-01-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-07
Last Update Post Date:
2025-10-17
Last Update Post Date Type:
ESTIMATED